MCM
PFE icon

Moore Capital Management’s Pfizer PFE Stock Holding History

Moore Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-565,500
Closed -$15M – 593
2024
Q4 		$15M Buy
+565,500
New +$15.3M 0.17% 136
2023
Q4 		– Sell
-150,000
Closed -$4.98M – 518
2023
Q3 		$4.98M Buy
+150,000
New +$5.3M 0.09% 164

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Moore Capital Management's PFE Position: Q2 2025 in Review

Moore Capital Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 250,000 shares — an estimated $6.33M sold.

Moore Capital Management first reported a position in PFE in Q3 2013 and held it in 10 quarters. The position peaked at $17.1M in Q4 2014. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Moore Capital Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Moore Capital Management sold 250,000 Pfizer shares in Q2 2025, an estimated $6.33M.
  • Moore Capital Management first reported a position in Pfizer in Q3 2013 and held it in 10 quarters.
  • Moore Capital Management's Pfizer position peaked at $17.1M in Q4 2014.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Moore Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.